ursodeoxycholic acid Tablets 300 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17459
This pharmaceutical company is a rapidly growing force in the global healthcare market, specializing in high-quality, affordable medications. They boast a diverse product portfolio encompassing prescription drugs, over-the-counter medications, and supplements, targeting key therapy areas like anti-Alzheimer's, asthma, diabetes, and cardiovascular health. The company holds WHO-GMP certifications and international approvals, underscoring their commitment to quality and regulatory compliance. Their manufacturing facilities are equipped with state-of-the-art technology, ensuring the production of safe and effective medicines. They distribute their products widely across multiple regions, including South East Asia and the Middle East, leveraging a robust network of distributors and consignees. Their mission is to provide accessible and affordable healthcare solutions worldwide, aiming to be a trusted partner for high-quality pharmaceuticals globally.
Ursodeoxycholic acid is a bile acid used to treat gallstones as well as to treat and prevent the progression of cystic fibrosis-related liver disorders. Suppliers of ursodeoxycholic acid market it in the form of 150mg, 250mg and 500mg oral tablets and capsules.
The market for ursodeoxycholic acid is relatively competitive, populated with numerous manufacturing companies and suppliers. The largest manufacturers of ursodeoxycholic acid market globally are companies Mitsubishi Tanabe Pharma, Daewoong Chemical, and PharmaZell, Glenmark Pharmaceuticals, Dipharma Francis, Errengierre, and Grindeks.
Ursodeoxycholic acid suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified ursodeoxycholic acid manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 50 (250mg) tablets of ursodeoxycholic acid fall into an approximate range of 12,00 EUR to 15,00 EUR, whereas the equivalent amount of 500mg tablets cost from 25,00 EUR to 30,00 EUR.